Back to 
Invesco Ltd.
Invesco Ltd.
CAPR
9 quarters
Position history for Invesco Ltd.'s holdings in Capricor Therapeutics, Inc.
Yes. Invesco holds 29,552 shares of CAPR (Capricor Therapeutics), worth $711,612, as of its Q2 2026 13F filing. It reduced the position by 155,820 shares (-84.1%) from Q1 2026. Invesco has held CAPR since Q2 2024, across 9 quarterly 13F filings.
Current Value
$711,612
Current Shares
29,552
Total Value Change
+$653,733
Total Shares Change
+17,418
Quarter-by-Quarter History
Other major holders of CAPR: BlackRock, Inc., State Street Corp., Vanguard Group Inc.